user

Adherence (adh) to and beliefs about oral anticancer medications (OAMs) in patients (pts) with metastatic renal cell carcinoma (mRCC).

被引：0
|
作者：
Geynisman, Daniel M.
Hlubocky, Fay J.
Kocherginsky, Masha
Stadler, Walter Michael
Daugherty, Christopher
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[2] Univ Chicago Med, Chicago, IL USA
[3] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA
[4] Univ Chicago, Chicago, IL 60637 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 31期
关键词：
D O I：
10.1200/jco.2013.31.31_suppl.25
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
25
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Adherence (adh) to and beliefs about oral anticancer medications (OAMs) in metastatic renal cell carcinoma (mRCC) patients (pts): A single-center pilot study in the United States.
    Geynisman, Daniel M.
    Hlubocky, Fay J.
    Kocherginsky, Masha
    Duster, Sarah M.
    Gomez, Joseline X.
    Stadler, Walter Michael
    Daugherty, Christopher
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Oral Anticancer Agent (OAA) Adherence and Survival in Elderly Patients With Metastatic Renal Cell Carcinoma (mRCC)
    Spees, Lisa P.
    Greiner, Melissa A.
    Dinan, Michaela A.
    Wilson, Lauren E.
    Pritchard, Jessica E.
    Zhang, Tian
    Kaye, Deborah
    George, Daniel
    Scales, Charles D.
    Baggett, Chris D.
    Gross, Cary P.
    Leapman, Michael S.
    Wheeler, Stephanie B.
    [J]. UROLOGY, 2022, 168 : 129 - 136
  • [3] Oral anticancer agent (OAA) adherence and survival in elderly patients with metastatic renal cell carcinoma (mRCC).
    Dinan, Michaela Ann
    Wilson, Lauren E.
    Greiner, Melissa A.
    Spees, Lisa
    Pritchard, Jessica
    Zhang Tian
    Kaye, Deborah
    George, Daniel J.
    Scales, Charles D.
    Wheeler, Stephanie B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [4] Active surveillance (AS) in the management of patients (pts) with metastatic renal cell carcinoma (mRCC).
    Ivanyi, Philipp
    Eggers, Hendik
    Seidel, Christoph Alexander
    Reuter, Christoph
    Ganser, Arnold
    Gruenwald, Viktor
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] Prognostic impact of lymphnode metastasis in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Ivanyi, P.
    Tiemann, M. -L.
    Eggers, H.
    Reuter, C.
    Peters, I.
    Kuczyk, M.
    Ganser, A.
    Gruenwald, V.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 80 - 80
  • [6] Efficacy and safety of everolimus in elderly patients (pts) with metastatic renal cell carcinoma (mRCC)
    Osanto, S.
    Hutson, T. E.
    Calvo, E.
    Escudier, B. J.
    Oudard, S.
    Porta, C.
    Bracarda, S.
    Grunwald, V.
    Ravaud, A.
    Motzer, R. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Renal safety of sunitinib treatment: A prospective study for patients (pts) with metastatic renal cell carcinoma (mRCC)
    Billemont, B.
    Rixe, O.
    Meric, J. B.
    Alexandre, J.
    Goldwasser, F.
    Izzedine, H.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 36 - 36
  • [8] Skin toxicity of sunitinib: Prospective analysis in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Billemont, B.
    Barete, S.
    Meric, J. B.
    Moguelet, P.
    Frances, C.
    Chosidow, O.
    Goldwasser, F.
    Rixe, O.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Characterizing fatigue associated with sunitinib (SU) in patients (pts) with metastatic renal cell carcinoma (mRCC).
    Cella, David
    Davis, Mellar P.
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Hahn, Elizabeth A.
    Korytowsky, Beata
    Bhattacharyya, Helen
    Sandin, Rickard
    Beaumont, Jennifer L.
    Matczak, Ewa
    Motzer, Robert John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] Phase II study of lenalidomide in patients (pts.) with metastatic renal cell carcinoma (MRCC).
    Choueiri, T. K.
    Dreicer, R.
    Rini, B. I.
    Elson, P.
    Garcia, J.
    Mekhail, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 226S - 226S
12345